Cho Yun-Ho, Park Jin Joo, Lee Hae-Young, Kim Kye Hun, Yoo Byung-Su, Kang Seok-Min, Baek Sang Hong, Jeon Eun-Seok, Kim Jae-Joong, Cho Myeong-Chan, Chae Shung Chull, Oh Byung-Hee, Choi Dong-Ju
Cardiovascular Center, Division of Cardiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Gumiro 166, Bundang, Seongnam, Gyeonggi-Do, Republic of Korea.
Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital and Gyeongsang National University School of Medicine, Changwon, Korea.
Clin Res Cardiol. 2024 Aug 27. doi: 10.1007/s00392-024-02469-4.
Cachexia and sarcopenia are common among heart failure (HF) patients and are linked to poor outcomes. As serum creatinine levels are influenced by both renal function and muscle mass, our study aimed to investigate the relationship between serum creatinine levels and mortality in acute HF patients.
We enrolled 5198 consecutive acute HF patients from the Korea Acute Heart Failure (KorAHF) registry, excluding those on renal replacement therapy. Patients were categorized into five groups based on their discharge serum creatinine levels: low (< 0.6 mg/dL), reference (0.6-0.89 mg/dL), upper normal (0.9-1.19 mg/dL), high (1.2-1.49 mg/dL), and very high (≥ 1.5 mg/dL). The primary endpoint was post-discharge all-cause mortality.
The mean creatinine level was 1.20 ± 0.88 mg/dL. Notably, 335 (6.4%) patients had serum creatinine levels < 0.6 mg/dL. These patients were younger (mean age, 67 years) and more likely to have a low BMI (< 18.5 kg/m) compared to the reference group (15.3% vs. 6.4%). Over a median follow-up of 975 days, 1743 (34.8%) patients died. We observed a J-shaped relationship between serum creatinine levels and mortality, with both low and high levels associated with increased mortality. After adjusting for covariates, including age, sex, body mass index, diabetes, hypertension, smoking, malignancy, atrial fibrillation on electrocardiography, levels of C-reactive protein, sodium, hemoglobin, albumin, brain natriuretic peptide, de novo heart failure, use of beta-blockers, renin-angiotensin system inhibitors, and mineralocorticoid receptor antagonists, patients with serum creatinine levels < 0.6 mg/dL had a 33% higher risk of all-cause mortality (HR, 1.33; 95% CI, 1.06 to 1.66) compared to those with levels of 0.6-0.89 mg/dL. However, BUN, which is not affected by muscle metabolism, exhibited a linear relationship with mortality.
Among acute HF patients, there exists a J-shaped relationship between discharge serum creatinine levels and mortality, highlighting the increased mortality risk in individuals with very low serum creatinine levels.
恶病质和肌肉减少症在心力衰竭(HF)患者中很常见,且与不良预后相关。由于血清肌酐水平受肾功能和肌肉量两者影响,我们的研究旨在调查急性HF患者血清肌酐水平与死亡率之间的关系。
我们从韩国急性心力衰竭(KorAHF)登记处纳入了5198例连续的急性HF患者,排除接受肾脏替代治疗的患者。根据出院时血清肌酐水平将患者分为五组:低水平(<0.6mg/dL)、参照水平(0.6 - 0.89mg/dL)、正常上限(0.9 - 1.19mg/dL)、高水平(1.2 - 1.49mg/dL)和非常高水平(≥1.5mg/dL)。主要终点是出院后全因死亡率。
肌酐平均水平为1.20±0.88mg/dL。值得注意的是,335例(6.4%)患者血清肌酐水平<0.6mg/dL。与参照组相比,这些患者更年轻(平均年龄67岁),且体重指数较低(<18.5kg/m)的可能性更大(15.3%对6.4%)。在975天的中位随访期内,1743例(34.8%)患者死亡。我们观察到血清肌酐水平与死亡率之间呈J形关系,低水平和高水平均与死亡率增加相关。在对包括年龄、性别、体重指数、糖尿病、高血压吸烟、恶性肿瘤、心电图显示的心房颤动、C反应蛋白水平、钠、血红蛋白、白蛋白、脑钠肽、新发心力衰竭、使用β受体阻滞剂、肾素 - 血管紧张素系统抑制剂和盐皮质激素受体拮抗剂等协变量进行调整后,血清肌酐水平<0.6mg/dL的患者全因死亡风险比血清肌酐水平为0.6 - 0.89mg/dL的患者高33%(风险比,1.33;95%置信区间,1.06至1.66)。然而,不受肌肉代谢影响的尿素氮与死亡率呈线性关系。
在急性HF患者中,出院时血清肌酐水平与死亡率之间存在J形关系,突出了血清肌酐水平极低的个体死亡率增加的风险。